- Home
- CUBE vs CORT Comparison
CUBE vs CORT Comparison
Compare CUBE & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CUBE | CORT |
|---|---|---|
| Founded | 2004 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 8.6B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | CUBE | CORT |
|---|---|---|
| Price | $35.95 | $80.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 6 |
| Target Price | $45.00 | ★ $130.20 |
| AVG Volume (30 Days) | ★ 2.1M | 999.2K |
| Earning Date | 10-30-2025 | 11-04-2025 |
| Dividend Yield | ★ 5.91% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.55 | 0.87 |
| Revenue | ★ $1,110,530,000.00 | $741,172,000.00 |
| Revenue This Year | $3.49 | $23.96 |
| Revenue Next Year | $3.16 | $43.40 |
| P/E Ratio | ★ $23.17 | $94.62 |
| Revenue Growth | 4.09 | ★ 17.92 |
| 52 Week Low | $34.24 | $49.00 |
| 52 Week High | $44.13 | $117.33 |
Technical Indicators
Market Signals| Indicator | CUBE | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 44.88 | 47.30 |
| Support Level | $35.25 | $80.38 |
| Resistance Level | $36.98 | $85.34 |
| Average True Range (ATR) | 0.60 | 3.31 |
| MACD | 0.05 | -0.60 |
| Stochastic Oscillator | 43.64 | 24.52 |
Price Performance
Historical ComparisonAbout CUBE CubeSmart
CubeSmart is a real estate investment trust that acquires, owns, and manages self-storage facilities throughout the United States. The company's real estate portfolio is composed of buildings with numerous enclosed storage areas for both residential and commercial customers to rent mainly on a month-by-month basis. Majority of CubeSmart's facilities are located in Florida, Texas, California, New York, and Illinois. Cumulatively, these states account for both the majority of the square footage in the company's real estate portfolio and the majority of its revenue. The company derives nearly all of its revenue from rental income from tenants utilizing its storage facilities.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.